Receptor activator of NF-kappaB (RANK) ligand (RANKL), expressed by cells of the osteoblast lineage binds to RANK, induces signaling and a gene expression cascade that leads to osteoclast differentiation and activation.
Also to know is, are rank receptors on osteoclasts?
“RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis”.
Just so, what are osteoclasts?
Osteoclasts are the cells that degrade bone to initiate normal bone remodeling and mediate bone loss in pathologic conditions by increasing their resorptive activity. They are derived from precursors in the myeloid/ monocyte lineage that circulate in the blood after their formation in the bone marrow.
What is RANKL in osteoporosis?
RANKL as a Promising Therapeutic Target for Osteoporosis
RANKL is a homotrimeric transmembrane protein expressed by osteocytes, macrophages, osteoblasts, bone marrow stem cells and activated T lymphocytes (Lacey et al., 2012; Mori et al., 2013).
What is RANKL RANK OPG pathway?
The RANK/RANKL/OPG Pathway. The RANKL/RANK/OPG system is known for its roles in osteoclasts maturation, bone modeling, and bone remodeling. Receptor activator of NF-kB (RANK), receptor activator of NF-kB ligand (RANKL), and osteoprotegerin (OPG) are the main components of this signaling system.
What protein S is are a decoy for the receptor activator of nuclear factor ΚB ligand RANKL that can inhibit osteoclast precursor differentiation?
What role does the OPG RANK RANKL have on bone development?
RANKL/RANK signaling regulates osteoclast formation, activation and survival in normal bone modeling and remodeling and in a variety of pathologic conditions characterized by increased bone turnover. OPG protects bone from excessive resorption by binding to RANKL and preventing it from binding to RANK.
When RANKL binds to RANK what occurs?
RANKL binds to RANK on the surface of osteoclast precursors and recruits the adapter protein, TRAP6, leading to activation of NF-κB through phosphorylation and inactivation of inhibitory kappa kinases (IKKs) and NF-κB inhibitory kinase (not shown here). This induces activation of c-Fos.
Where is RANKL produced?
RANKL is expressed in several tissues and organs including: skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.